|
Real-time Estimate
Tradegate
12:13:21 16/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 210.55 EUR | +0.26% |
|
+3.05% | -10.85% |
| 09-11 | AlphaValue/Baader Europe Sees UCB Share Drop as 'Rare Window of Affordability'; Price Target Up | MT |
| 09-10 | UCB: A rare window of affordability |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 77.3B | |||||
| 59.52B | |||||
| 57.4B | - | ||||
| 47.91B | |||||
| 46.2B |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
